Diabetes oral Drug chart

Diabetes oral Drug chart - Drug FBG decrea se A1C Decrease...

Info iconThis preview shows pages 1–2. Sign up to view the full content.

View Full Document Right Arrow Icon
Drug FBG decrea se A1C Decrease Max Effect MOA OTHER METFORMIN 50 1.5 3-4 wks Insulin sensitizer. Decreases GI glucose uptake glucose uptake Initiated @ diag. GI AE might want to titrate-take w/food. Can increase lactic acid levels— contraindicated in live dys, inc OH intake, CrCl<60, SrCr>1.5 male &>1.4 female, DX of poor oxygenation & perfusion-Lung DX, CV failure, COPD, Hypoperfusion, Renal insufficiency., >80yrs, 48hrs post radiographic dye Benefit is CHEAP, WEIGHT LOSS , NO HYPO AS MONO, PRESERVES BETA CELLS, SMALL DEC. IN TG/BP Sulfonylurea’s Secretogogs 50-80 From 9% see 2% reduction 2 wks Block SER1 on ATP K+ channel on beta cell surface, which increases insulin release. Ryan says blocks SHC pathway Cause weight gain (5-15lbs), HYPOGLYCEMIA , Rash- rare. GI-rare NEVER SKIP MEALS , OH<2drinks/day. . WORRY A BOUT B CELL BURN OUT BECAUSE WORKING AT BETA CELLS. CEASE TO WORK AFTER 4- 5 YRSS THIOZOLIDIONS —whatever PHERIPHERY INSULIN SENSATIZER— MAINLY WORKIN AT ADIPOCYTE TO
Background image of page 1

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
Image of page 2
This is the end of the preview. Sign up to access the rest of the document.

This note was uploaded on 10/25/2011 for the course PHARM 552 taught by Professor R/y/j during the Spring '11 term at MCPHS.

Page1 / 2

Diabetes oral Drug chart - Drug FBG decrea se A1C Decrease...

This preview shows document pages 1 - 2. Sign up to view the full document.

View Full Document Right Arrow Icon
Ask a homework question - tutors are online